Marshall Wace’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.27M | Buy |
42,797
+16,110
| +60% | +$2.1M | 0.01% | 1253 |
|
|
2026
Q1 | $3.45M | Buy |
26,687
+25,187
| +1,679% | +$3.62M | ﹤0.01% | 1498 |
|
|
2025
Q4 | $214K | Sell |
1,500
-1,040
| -41% | -$139K | ﹤0.01% | 2572 |
|
|
2025
Q3 | $305K | Buy |
+2,540
| New | +$322K | ﹤0.01% | 2424 |
|
|
2024
Q3 | – | Sell |
-5,647
| Closed | -$671K | – | 2707 |
|
|
2024
Q2 | $671K | Sell |
5,647
-54,007
| -91% | -$5.68M | ﹤0.01% | 1848 |
|
|
2024
Q1 | $6.4M | Sell |
59,654
-2,294
| -4% | -$228K | 0.01% | 896 |
|
|
2023
Q4 | $6.18M | Buy |
+61,948
| New | +$6.06M | 0.01% | 835 |
|
|
2023
Q2 | – | Sell |
-2,401
| Closed | -$396K | – | 2673 |
|
|
2023
Q1 | $396K | Buy |
+2,401
| New | +$413K | ﹤0.01% | 2194 |
|
|
2021
Q4 | – | Sell |
-2,056
| Closed | -$479K | – | 4047 |
|
|
2021
Q3 | $479K | Buy |
+2,056
| New | +$431K | ﹤0.01% | 2411 |
|
|
2021
Q2 | – | Sell |
-2,887
| Closed | -$593K | – | 2833 |
|
|
2021
Q1 | $593K | Buy |
+2,887
| New | +$610K | ﹤0.01% | 1878 |
|
|
2020
Q3 | – | Sell |
-16,671
| Closed | -$3.07M | – | 1738 |
|
|
2020
Q2 | $3.07M | Buy |
16,671
+16,373
| +5,494% | +$3.25M | 0.02% | 628 |
|
|
2020
Q1 | $60K | Buy |
+298
| New | +$57.4K | ﹤0.01% | 1397 |
|
|
2019
Q3 | – | Sell |
-17,945
| Closed | -$4.52M | – | 1787 |
|
|
2019
Q2 | $4.52M | Buy |
17,945
+3,438
| +24% | +$797K | 0.04% | 521 |
|
|
2019
Q1 | $3.47M | Sell |
14,507
-69,335
| -83% | -$16.6M | 0.03% | 575 |
|
|
2018
Q4 | $19.3M | Sell |
83,842
-69,418
| -45% | -$17.1M | 0.2% | 119 |
|
|
2018
Q3 | $43.3M | Buy |
+153,260
| New | +$44.9M | 0.37% | 60 |
|
|
2016
Q4 | – | Sell |
-20,120
| Closed | -$2.54M | – | 1034 |
|
|
2016
Q3 | $2.54M | Sell |
20,120
-115,336
| -85% | -$13.9M | 0.02% | 544 |
|
|
2016
Q2 | $15.3M | Buy |
135,456
+22,019
| +19% | +$2.29M | 0.13% | 181 |
|
|
2016
Q1 | $11.8M | Sell |
113,437
-1,117
| -1% | -$107K | 0.11% | 189 |
|
|
2015
Q4 | $12.9M | Buy |
114,554
+64,003
| +127% | +$7.07M | 0.12% | 194 |
|
|
2015
Q3 | $5.54M | Buy |
+50,551
| New | +$5.41M | 0.07% | 276 |
|
|
2014
Q2 | – | Sell |
-7,219
| Closed | -$432K | – | 990 |
|
|
2014
Q1 | $432K | Buy |
+7,219
| New | +$445K | 0.01% | 610 |
|
Other funds holding ICUI
Marshall Wace's ICUI Position: Q2 2026 in Review
Marshall Wace increased its ICU Medical (ICUI) stake by 60% in Q2 2026, buying an estimated $2.1M and bringing the position to 42,797 shares worth $6.27M. The position accounts for 0.01% of the portfolio, ranked #1253.
Marshall Wace first reported a position in ICUI in Q1 2014 and has held it in 22 quarters since. The position peaked at $43.3M in Q3 2018. 288 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.
- Marshall Wace held 42,797 shares of ICU Medical worth $6.27M as of Q2 2026.
- Marshall Wace bought 16,110 ICU Medical shares in Q2 2026, an estimated $2.1M.
- ICU Medical made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1253 holding.
- Marshall Wace first reported a position in ICU Medical in Q1 2014 and has held it in 22 quarters since.
- Marshall Wace's ICU Medical position peaked at $43.3M in Q3 2018.
- 288 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.